Mycoplasma pneumoniae

June 23, 2016June 23, 2016

Positive Data on Lefamulin for CAB Pneumonia Presented by Nabriva

News, Pneumonia

Nabriva Therapeutics AG recently announced new research findings for its lead product candidate lefamulin, the first pleuromutilin antibiotic available for systemic administration in humans. The company is developing both intravenous and ... Read more

May 5, 2016May 5, 2016

Rapid Diagnostic Test for Mycoplasma pneumoniae Receives EU Mark of Approval

News, Pneumonia

Meridian Bioscience, Inc., recently announced that its new molecular diagnostic test for Mycoplasma pneumoniae, illumigene Mycoplasma Direct assay, has received the CE mark, which establishes that the product meet the European Union’s safety, health ... Read more

April 6, 2016May 13, 2016

Pneumonia Epidemic on Rise in Beijing; Diagnoses Doubled in Children in 2015

News, Pneumonia

Investigators from the Capital Institute of Pediatrics in Beijing, China, identified an increase in infections caused by Mycoplasma pneumoniae almost a year ago. By December 2015, the pathogen had already been ... Read more

January 2, 2015November 6, 2015

Newly Discovered Toxin May Cause Lung Inflammation, Contribute to Asthma & Other Lung Diseases

Asthma, News

On December 23, 2014, scientists from the University of Texas Health Science Center at San Antonio published a new study describing a novel way that a bacterial toxin might contribute to asthma and other ... Read more